$PTLA $25.65 Sold two tranches here to lock in gains as it runs to it's catalyst. PDUFA August 21 under priority review for BLA seeking FDA approval to reverse the blood thinning activity. Still holding 1/4 position with a 3% trailing stop. If I'm stopped out, I will look to re-enter on any pullback as this still has some time to run.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.